We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Noninvasive Optical Measurement of Critical Care Neonates

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01483703
First Posted: December 1, 2011
Last Update Posted: February 10, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
  Purpose
The purpose of this study is to determine whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This study device is called laser speckle imaging.

Condition Intervention
Signs and Symptoms Device: Laser Speckle Imaging

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Noninvasive Optical Measurement of Critical Care Neonates

Resource links provided by NLM:


Further study details as provided by Beckman Laser Institute and Medical Center, University of California, Irvine:

Primary Outcome Measures:
  • Medical tool [ Time Frame: up to 12 months ]
    Laser Speckle Imaging device to image superficial cerebral blood flow in the infant's head


Enrollment: 6
Study Start Date: May 2010
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Diagnostic tool
Laser Speckle Imaging of Critical Care Neonates
Device: Laser Speckle Imaging
Laser Speckle Imaging of Critical Care Neonates

Detailed Description:
The researchers can use the laser speckle imaging device to image superficial cerebral blood flow in the infant's head. The researchers can quantify blood flow and measured vessel diameter, versus actual diameter assessed with conventional digital camera imaging.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 6 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children
Criteria

Inclusion Criteria:

  • New born or infant

Exclusion Criteria:

  • non- new born or infant
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01483703


Locations
United States, California
CHOC
Orange, California, United States, 92868
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Bernard Choi, PhD Beckman Laser Institute, UCI
  More Information

Responsible Party: Beckman Laser Institute and Medical Center, Bernard Choi, Ph.D., Assistant Professor Biomedical Engineering, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01483703     History of Changes
Other Study ID Numbers: NIH-LAMMP-2010-8163
First Submitted: November 29, 2011
First Posted: December 1, 2011
Last Update Posted: February 10, 2017
Last Verified: February 2017

Additional relevant MeSH terms:
Signs and Symptoms